Global Flecainide Market is expected to grow at a CAGR of 3.2% from 2020 to 2027 – Dagoretti Market Reports by info@dagorettinews.com November 21, 2025 Market Research Flecainide is classified as a class 1 antiarrhythmic drug which received USFDA approval in 1985 for the treatment of atrial… Read More